Quest Diagnostics Incorporated (DGX)
NYSE
242.95
-1.66 (-0.68%)
Closed
Aug 28, 2026
Day's Range
242.74245.02
52 wk Range
171.18247.19
Financial Statements - DGX - Quest Diagnostics Incorporated
Revenue
11.03B▲ 11.8%
Net Income
1.04B▲ 13.6%Net Margin 9.5%
EBITDA
2.16B▲ 14.3%
Free Cash Flow
1.35B▲ 49.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 11.03B | 9.87B | 9.25B | 9.88B | 10.78B | 9.43B |
| Cost of Goods | 7.37B | 6.62B | 6.19B | 6.45B | 6.57B | 5.80B |
| Gross Profit | 3.66B | 3.24B | 3.05B | 3.43B | 4.20B | 3.63B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.55B | 1.34B | 1.26B | 1.42B | 2.38B | 1.97B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 26M | 30M | 20M | -55M | 369M | 76M |
| Pre Tax Income | 1.31B | 1.17B | 1.13B | 1.23B | 2.59B | 1.88B |
| Income Tax | 314M | 273M | 248M | 264M | 597M | 460M |
| Net Income | 1.04B | 921M | 908M | 1.01B | 2.08B | 1.49B |
| EPS Basic | 8.87 | 7.78 | 7.59 | 8.1 | 15.85 | 10.62 |
| EPS Diluted | 8.75 | 7.69 | 7.49 | 7.97 | 15.55 | 10.47 |
| Basic Shares Outstanding | 111M | 111M | 112M | 116M | 125M | 134M |
| Diluted Shares Outstanding | 111M | 111M | 112M | 116M | 125M | 134M |
| Ebit | 1.59B | 1.40B | 1.29B | 1.38B | 2.75B | 2.05B |
| Ebitda | 2.16B | 1.89B | 1.73B | 1.82B | 3.15B | 2.41B |
| Net Income Continuous Operations | 1.04B | 921M | 908M | 1.01B | 2.08B | 1.49B |
| Minority Interests | -54M | -50M | -54M | -69M | -85M | -68M |
| Preferred Stock Dividends | 4M | 5M | 4M | 4M | 7M | 6M |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
